octanate®LV (human coagulation FVIII, VWF)

Only available in the UK

United Kingdom

Summary of Product Characteristics octanate® LV 100IU/ml

Summary of Product Characteristics octanate® LV 200IU/ml

Patient Information Leaflet octanate®LV 100IU/ml

Patient Information Leaflet octanate®LV 200IU/ml

United Kingdom: Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.

UK/P/UKON/C/V3 August 2020

This site is intended for UK healthcare professionals and may contain promotional information.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Octapharma by telephoning 0845 1300 522.

Product Information

Summary of Product Characteristics octanate® LV 100IU/ml

Summary of Product Characteristics octanate® LV 200IU/ml

Theapeutic Indications

Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).

Octanate LV can be used for all age groups.

This preparation does not contain von Willebrand factor in pharmacologically effective quantities and is therefore not indicated in von Willebrand disease.

Shelf Life & Storage

Shelf life two years. Store in a refrigerator (+2°C to +8°C).

Do not freeze. Keep the vials in the outer carton in order to protect from light.

Vial Sizes

Our licensed vial sizes are listed below:

  • Octanate LV 100IU/ml: 500 IU/ vial

  • Octanate LV 200 IU/ml: 1000IU/ vial

For questions about availability please contact customer services.


Legal classification: Prescription-only Medicine

Basic NHS cost: £0.30p per IU


UK/P/UKONHCP/C/V3 August 2020